Stayble Therapeutics AB (publ) (STO: STABL)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.410
+0.012 (3.02%)
Dec 23, 2024, 5:21 PM CET
32.69%
Market Cap 17.93M
Revenue (ttm) 376.00K
Net Income (ttm) -15.69M
Shares Out 43.72M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 38,213
Open 0.398
Previous Close 0.398
Day's Range 0.396 - 0.428
52-Week Range 0.190 - 1.050
Beta 0.26
Analysts n/a
Price Target n/a
Earnings Date Feb 20, 2025

About Stayble Therapeutics AB

Stayble Therapeutics AB (publ) develops injectable treatment for chronic pain triggered by disc degeneration. The company develops STA363, an injection into the disc that targets chronic low back and leg pain. Stayble Therapeutics AB (publ) was incorporated in 2015 and is based in Gothenburg, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 3
Stock Exchange Nasdaq Stockholm
Ticker Symbol STABL
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.